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Validation and Use of a Musculoskeletal Gait
Model to Study the Role of Functional
Electrical Stimulation
Ziyun Ding , Nur Liyana Azmi , and Anthony M. J. Bull
Abstract—Objective: Musculoskeletal modeling has been
used to predict the effect of functional electrical stimula-
tion (FES) on the mechanics of the musculoskeletal sys-
tem. However, validation of the resulting muscle activations
due to FES is challenging as conventional electromyogra-
phy (EMG) recording of signals from the stimulated muscle
is affected by stimulation artefacts. A validation approach
using a combination of musculoskeletal modeling and EMG
was proposed, whereby the effect on nonstimulated mus-
cles is assessed using both techniques. The aim is to quan-
tify the effect of FES on biceps femoris long head (BFLH)
and validate this directly against EMG of gluteus maximus
(GMAX). The hypotheses are that GMAX activation corre-
lates with BFLH activation; and the muscle activation during
FES gait can be predicted using musculoskeletal modeling.
Methods: Kinematics, kinetics, and EMG of healthy sub-
jects were measured under four walking conditions (normal
walking followed by FES walking with three levels of BFLH
stimulation). Measured kinematics and kinetics served as
inputs to the musculoskeletal model. Results: Strong posi-
tive correlations were found between GMAX activation and
BFLH activation in early stance peak (R = 0.78, p = 0.002)
and impulse (R = 0.63, p = 0.021). The modeled peak
and impulse of GMAX activation increased with EMG peak
(p < 0.001) and impulse (p = 0.021). Conclusion: Muscu-
loskeletal modeling can be used reliably to quantify the ef-
fect of FES in a healthy gait. Significance: The validation
approach using EMG and musculoskeletal modeling devel-
oped and tested can potentially be applied to the use of FES
for other muscles and activities.
Index Terms—Functional electrical stimulation, muscu-
loskeletal modelling.
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I. INTRODUCTION
FUNCTIONAL electrical stimulation (FES) involvesutilising patterned electrical stimulation to nervous tissue
in order to activate muscles [1]. The beneficial effects of FES
have been demonstrated for individuals with neurological
pathologies [2]–[5]. Investigations have been made to artifi-
cially elicit and control lower limb muscle contraction via FES
thereby utilising the musculature and metabolic power supply
of individuals to generate locomotion [2], [4], [6]. In addition
to the restoration of lower limb movement, FES-aided gait has
also been shown to have potential benefits for individuals with
orthopaedic pathologies, including mitigation of medial knee
loading for patients with knee osteoarthritis (OA) [7], [8], and
improvement in knee stability for patients with anterior cruciate
ligament (ACL) injuries [9], [10].
In order to control graded force recruitment from selective
muscles and produce well-coordinated movement via FES, the
knowledge of muscle activations in magnitude and timing is im-
portant. Advances in computational musculoskeletal gait mod-
els provide promising, non-invasive determination of mechan-
ical loading in a musculoskeletal system. Such models take as
input measured kinematics (joint angles and segment positions)
and kinetics (ground reaction force and segmental parameters)
during gait to formulate the equations of motion; solving these
yields muscle, joint and ligament forces. However, validating
the results from the musculoskeletal models is a well-known
challenge [11]–[13]. Validation can be achieved at the level of
tendon forces, bone forces or joint contact forces using inva-
sive devices, for example instrumented prostheses [14], [15] or
tendon transducers [16]. Alternatively, validation is possible at
the level of muscle activations with surface electromyography
(EMG) [17], [18].
EMG signals are affected by the stimulation artefacts caused
by the stimulation current when FES is used. This has been
partially addressed in the literature with, for example, use of an
EMG-amplifier with shut-down control [19], advanced filtering
procedures [19]–[21], and optimising the positioning of the
EMG electrodes in relation to the stimulation electrodes [20],
[22]. These approaches do not fully eliminate the stimulation
artefacts.
Due to the difficulties in detecting EMG signals from the
same electrically stimulated muscle, the approach proposed in
this study is to measure EMG signals from a non-stimulated
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muscle that is sufficiently far removed from the stimulator. The
muscle must also have the feature that it is likely to change
its activation due to the disrupted mechanics produced by the
stimulated muscle’s increased activation. It is therefore neces-
sary to identify such a pair of muscles, where the activation of
one is likely to have an effect on the activation of the second
muscle. Biceps femoris long head (BFLH) and gluteus max-
imus (GMAX) is a pair of the muscle candidates. BFLH acts as
a knee flexor, and potentially compensates for weak hip exten-
sors such as GMAX [23]. Clinically, stimulation of BFLH via
FES has been used to generate hip extension for patients with
paraplegia [6], and improve knee stability for patients with ACL
deficiency [24]. Therefore, BFLH is a clinically useful muscle
in FES assisted gait. The aim of this study is to quantify the
effect of FES on BFLH during gait utilising a musculoskeletal
model and validate this directly against EMG of GMAX. The
hypotheses of the study are that: GMAX activation correlates
with BFLH activation; and the muscle activation pattern during
FES gait with stimulation of BFLH can be predicted from the
computational MSK model.
II. METHODS AND MATERIALS
The hypotheses were tested through computational mod-
elling, three-dimensional gait analysis of healthy subjects under
four walking conditions (normal walking followed by FES walk-
ing implemented in three output current amplitudes on BFLH),
and the simultaneous measurement of EMG of GMAX. Thirteen
healthy subjects (5 males and 8 females; mean height 1.65 ±
0.12 m; mass 64 ± 13 kg; age 26 ± 3 years) participated in
the study. This study was approved by the institutional research
ethics committee of Imperial College London and written in-
formed consent was obtained from all participants.
A. Data Collection
Kinematic and kinetic data were collected in the motion
laboratory, Department of Bioengineering, Imperial College
London, UK. Eighteen retro-reflective markers were placed on
the pelvis and the right lower limb (see Fig. 1) [10]. Their tra-
jectories were captured at 200 Hz using a ten-camera motion
capture system (VICON, Oxford Metrics Group, UK). Ground
reaction forces of the right limb were recorded at 2000 Hz from
a force plate (Kistler, Kistler Instrument AG, Switzerland). Ini-
tially, subjects performed six normal walking trials along an
approximately six-metre level walkway at a self-selective com-
fortable walking speed, taking several steps prior to landing the
right foot entirely on the force plate, and continuing for several
steps. Following the normal walking trials, the skin of BFLH
region was cleaned with a 70% isopropyl alcohol wipe and al-
lowed to dry in seconds. Two rubber and gel electrodes (7 cm
in diameter, PALS, Axelgaard manufacturing co., ltd, USA)
were placed in the region: one in the centre between the ischial
tuberosity to the lateral femoral epicondyle and the other one ap-
proximately 10 cm distally to the first (Fig. 1). Electrical stimuli
were delivered via the electrodes from a two-channel stimulator
(O2CHS II, Odstock Medical Limited, UK), set at 40 Hz fre-
quency with a pulse width of approximately 120 μs; this setting
Fig. 1. Optical motion tracking markers and FES electrodes
positioning.
was tolerated by the majority of subjects in our previous study
[10]. The output current amplitude was set to three stimulation
levels of 40 mA, 60 mA and 80 mA. Six walking trials were
measured for each stimulation level. To test that the BFLH stim-
ulation was consistently applied between subjects, prior to FES
gait, subjects were asked to stand with their legs straight and
the stimulator was activated. The electrode positions and stim-
ulation level were confirmed when a clear contraction of BFLH
was observed through the resulting flexion of the right knee.
Surface EMG (Delsys, Trigno Wireless EMG System, USA)
was sampled at 2000 Hz for BFLH and GMAX of the right limb.
According to the SENIAM recommendations [25] sensors were
placed at halfway along the line between the ischial tuberosity
and the lateral femoral epicondyle for BFLH; and halfway along
the line between the sacral vertebrae and the greater trochanter
for GMAX. Prior to sensor placement, the skin area was shaved
and cleaned with alcohol wipe to reduce skin impedance and to
ensure electrode adhesion. During FES walking trials, the sensor
at the region of BFLH was replaced with the FES electrodes.
EMG was corrected for offset, high-pass filtered at 30 Hz using
a zero phase-lag, four order Butterworth filter and rectified. The
rectified signals were then low-pass filtered at 10 Hz [26].
B. Lower Limb Musculoskeletal Model
An open source musculoskeletal modelling software Free-
body was used (V2.1, [27], [28]). The segment-based lower
limb model consists of the foot, shank, thigh, pelvis and patella
segments. The model inputs are the kinematics data from the
retro reflective markers and the kinetics data from the force
plate. In terms of the inverse dynamics method, the model cal-
culates the intersegmental forces and moments at the proximal
end of each segment [29].
Freebody’s musculoskeletal dataset consists of 163 muscle
elements representing 38 lower limb muscles. The muscle at-
tachment sites, joint centres of rotation, and tibiofemoral contact
points were manually digitized from the MR imaging of a male
subject (1.83 m, 96.0 kg, 44.0 years) [27]. The model estimates
the muscular and joint reaction forces experienced by the lower
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limb during the recorded movement. The optimisation was per-
formed using the cost function in order to minimise the sum of
the cubed muscle activations [30] as:
Min
163∑
i=1
(
fi
fmaxi
)3
(1)
where fi is the muscle force of muscle element i (i =
1, . . . , 163) and fmaxi is the maximum muscle force of muscle
element i, which is determined by multiplying published physio-
logical cross-sectional areas of muscle element i by an assumed
maximum muscle stress of 31.39 N/cm2 [31], constrained by
the equations of motion of the whole lower limb as:
[
Si
M i
]
=
[
miE3×3 03×3
mici Ii
] [
ai − g
θ¨i
]
+
[
03×1
θ˙i × Ii θ˙i
] [
E3×3 03×3
di E3×3
] [
Si−1
M i−1
]
(2)
where i is the segment number or joint number (numbering
from distal to proximal), Si the proximal inter-segmental forces,
Si−1 the distal inter-segmental forces, M i the proximal inter-
segmental moments (notional joint moments), M i−1 the distal
inter-segmental moments (notional joint moments), I i the in-
ertia tensor, θ¨i the angular acceleration about COM, θ˙i the
angular velocity about the COM, ai the linear acceleration of
COM, mi the segment mass, E3X 3 the identity matrix, ci the
vector from the proximal joint to the segment COM and di is
the vector from the proximal to the distal joint.
C. Revised Optimisation Method
In order to simulate the effect of three FES current levels ap-
plied to BFLH, a modified optimisation method was used [10].
In this method the muscle force of BFLH is set as a constant
value during the stance phase which is equal to the muscle acti-
vation, c, times the maximum force of BFLH. As the attachment
sites of BFLH are on the shank and thigh segments, the equa-
tions of motion of the shank and thigh segments were modified
by the inclusion of an additional term to give:
[
Si
M i
]
=
[
miE3×3 03×3
mici I i
][
ai − g
θ¨i
]
+
[
03×1
θ˙i × Ii θ˙i
]
+
[
E3×3 03×3
di E3×3
] [
Si−1
M i−1
]
−
[
(c× fBF LHm ax ) · nBFLH
(c× fBF LHm ax ) · (rBFLH × nBFLH )
]
(3)
where c is a constant, fBFLH max the maximum force of BFLH,
nBFLH the line of action of BFLH and rBFLH the moment arm
of BFLH. The muscle forces of the remaining 162 muscles were
re-optimised based on the modified equations of motion. From
our previous study, a mean BFLH activation value of 0.208
reduces the peak anterior shear force below zero [10] which
is the maximum desired clinical outcome for those with ACL
deficiency. In this study, c was set to 0.10, 0.15 and 0.20; these
are all greater than the BFLH activation predicted from normal
optimisation and not greater than the maximum value required
from the previous study. Measured kinematics and kinetics dur-
ing normal walking and walking with FES currents of 40 mA,
60 mA and 80 mA were set as inputs for the normal optimisation
as well as for revised optimisation with c values of 0.10, 0.15
and 0.20, respectively.
D. Data Analysis and statistics
Per subject, three random selected walking trials for each
of the four conditions were processed. GMAX EMG activity
was defined as the processed signals normalized by the peak
value from 12 walking trials (3 walking trials × 4 conditions);
this varied from 0 to 1. EMG activity and modelled activation
were expressed as a percentage of the stance phase (0% is
right heel strike and 100% is right heel off). Time-integrated
measures (impulses) of EMG activity and modelled activation
were determined using the trapezoidal method of numerical
integration [32].
Statistical analysis was performed using SPSS (Version 24.0,
IBM Corp., USA). Significance was set at an alpha level of 0.05.
Linear regression analyses were performed to evaluate the rela-
tionship between GMAX activation and BFLH activation. Dif-
ference between conditions at walking speed, early stance peak,
timing and impulse of EMG activity and modelled activation
of GMAX were assessed using either one-way repeated mea-
sures ANOVA (for normally distributed variables, as inspected
from the Shapiro-Wilk test) or Friedman tests (for non-normally
distributed variables). Where results were significant, pairwise
comparisons were performed with a Bonferroni correction for
multiple comparisons. The relationship between the modelled
muscle activation and EMG activity was investigated using the
Restricted Maximum Likelihood (REML) linear mixed model
analysis with subjects considered as the random factor. Depen-
dent variables were the predicted GMAX early stance peak and
impulse. EMG activity early stance peak and impulse were the
fixed effects.
III. RESULTS
Across 13 subjects, modelled GMAX activation was plotted
against the modelled BFLH activation (see Fig. 2). Strong pos-
itive correlations were found in early stance peak (R = 0.78,
p = 0.002) and impulse (R = 0.63, p = 0.021).
All subjects tolerated FES output currents of 40 mA and
60 mA. One subject did not tolerate the output current of 80 mA
and therefore results for FES walking with 80 mA stimulation
are for 12/13 subjects.
Measured and modelled variables during stance are reported
in Table I. Walking speed did not change across conditions
(p = 0.663). GMAX EMG activity peak occurred at 13%
(±2%) of stance, the timing of which did not change across con-
ditions (p = 0.470). Early stance peak and impulse of GMAX
EMG activity increased significantly from normal walking to
FES walking (p < 0.001). The musculoskeletal modelling pre-
dicted GMAX activation peak at 27% (±1%) of stance with a lag
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TABLE I
WALKING SPEED, MEASURED AND MODELLED VARIABLES OF GLUTEUS MAXIMUS (GMAX) DURING STANCE ACROSS CONDITIONS,
REPORTED AS MEAN (95% CI-CONFIDENCE INTERVAL)
Fig. 2. Relationships between GMAX activation and BFLH activa-
tion during early stance (0–33% of stance). (a) Activation peaks and
(b) activation impulses during early stance (n = 13).
of 14% (±2%) stance from the EMG measurement; this did not
change between conditions (p = 0.063). Modelled early stance
peak and impulse of GMAX activation increased significantly
from normal walking to FES walking (p < 0.001).
Measured EMG activity and modelled GMAX activation is
plotted in Fig. 3 for a representative subject. During early stance,
the peak EMG activity was lowest for normal walking, and
was positively correlated to current amplitude in FES walk-
ing. Greater c values in the optimisation models contributed
to greater GMAX activation. The increase of GMAX activa-
tion peak and impulse followed the increase of EMG peak and
TABLE II
RELATIONSHIP BETWEEN MODELLED ACTIVATION OF GLUTEUS MAXIMUS
AND EMG ACTIVITY IN EARLY STANCE PEAK AND IMPULSE
β (95% CI): regression coefficient (95% confidence interval) estimated by the linear mixed
model.
impulse (see Fig. 3(c) and (d)). Linear mixed models (see
Table II) confirmed that the modelled peak and impulse of
GMAX activations increased with EMG peak (p < 0.001) and
impulse (p = 0.021).
IV. DISCUSSIONS
The purpose of the study was to quantify the effect of FES on
BFLH using MSK modelling and validate this directly against
EMG of GMAX. The first hypothesis that GMAX activation
correlates with BFLH activation was confirmed through strong
positive correlations between GMAX activation and BFLH ac-
tivation in early stance peak (R = 0.78, p = 0.002) and impulse
(R = 0.63, p = 0.021). The second hypothesis that these acti-
vations can be quantified through musculoskeletal modelling
was also confirmed through validation using EMG. In the mus-
culoskeletal model, muscle activations were calculated, con-
strained by the experimental measured kinematics and kinetics,
and the modified BFLH activation to represent the stimula-
tion at the output currents of 40 mA, 60 mA and 80 mA. The
modelled early stance peak and impulse of GMAX activation
significantly correlated with the early stance peak and impulse
of EMG activity (p  0.021). However, there was a consis-
tent electromechanical delay of approximately 95 ms between
measured EMG and modelled activation. This is comparable to
other studies [33], [34]. Where others have used musculoskele-
tal models to quantify the effect of FES, none have validated
these models against simultaneously measured EMG signals.
An alternative to the method proposed here would be to use
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Fig. 3. (a) Measured EMG activity and (b) modelled activation from
the optimisation (opt) model of GMAX for a representative subject (S1).
Grey shaded areas indicate early stance phase. Measured EMG ac-
tivity versus (c) modelled activation in GMAX early stance peak and
(d) impulse for the same subject (S1). The other 12 subjects are shown
in Supplemental Figs. (a) and (b).
instrumented implant validation for studies combined with FES;
such as has been used to validate musculoskeletal modelling for
the hip and knee [15], [35].
In this study BFLH was selected because of its clinical rel-
evance: it has been used to generate hip extension for patients
with paraplegia [6] and to improve knee stability for patients
with ACL deficiencies [24]. There are other clinical conditions
where muscle activation could be used therapeutically, for exam-
ple, to correct foot drop following stroke through the stimulation
of tibialis anterior [5] or to attenuate muscle atrophy associated
with total knee arthroplasty through the stimulation of vastus
medialis [36]. The validation approach developed and tested
here could potentially be used in these applications.
This study has some limitations. First, the test cohort com-
prised only healthy, able-bodied subjects. In order to study the
clinical effect of FES on patients with neuromuscular disorders,
kinematics and kinetics from patient groups are required as the
movement strategies may be different from those of healthy sub-
jects [37]. Patient-specific musculoskeletal modelling for these
subjects would also enhance the modelling fidelity as some
parameters in the model may need to be adjusted in order to
represent the morphological changes due to the disorders, such
as changes in muscle size and attachments [38].
In this study, muscle force during gait was quantified by min-
imising the sum of muscle activations cubed [27]. When com-
pared with EMG measurement, this criterion has been shown to
accurately predict muscle activation pattern during gait, cycling
and other similar functional activities for healthy subjects [32],
[39]. However, for patients with neuromuscular disorders, other
physiological cost functions may be more representative of their
movement strategies [40], [41]. Additionally, we recognize that
EMG is not an absolute measure of muscle activation, and is
appropriately used as a measure of change in activation [13].
The experiments in this study consistently measured first nor-
mal walking and then FES walking at increasing intensities. This
approach was chosen to eliminate unwanted kinematics effects
due to fatigue and discomfort. However, this may have intro-
duced some bias and, therefore, for a systematic investigation
of FES intervention during gait, the walking conditions could
be randomized.
V. CONCLUSION
The study is the first to have validated the use of muscu-
loskeletal modelling to quantify the effect of FES during gait
in healthy subjects. The specific use, in this study, of FES for
BFLH was shown to predictably increase GMAX activation.
We propose using this approach to quantify the effect of FES on
other muscles and activities.
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